High rates of pulmonary artery occlusions in COVID‐19. A meta‐analysis

Background COVID‐19 patients are considered at high risk of venous thromboembolism (VTE). The real nature of pulmonary artery occlusions (PAO) in COVID‐19 has been questioned, suggesting that it is caused also by in situ thrombi, rather than only by emboli (PE) from peripheral thrombi. Methods We se...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	European journal of clinical investigation Ročník 51; číslo 1; s. e13433 - n/a
Hlavní autori:	Birocchi, Simone, Manzoni, Marco, Podda, Gian Marco, Casazza, Giovanni, Cattaneo, Marco
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England Blackwell Publishing Ltd 01.01.2021 John Wiley and Sons Inc
Predmet:	Anticoagulants - therapeutic use Case-Control Studies COVID-19 COVID-19 - epidemiology embolism and thrombosis Heparin Heparin - therapeutic use Heparin, Low-Molecular-Weight - therapeutic use Humans low‐molecular‐weight heparin Meta-analysis Original Original Papers Prevalence Pulmonary arteries Pulmonary Artery Pulmonary Embolism - epidemiology Pulmonary Embolism - prevention & control SARS coronavirus SARS-CoV-2 Thromboembolism Thrombosis Thrombosis - epidemiology Thrombosis - prevention & control Venous Thrombosis - epidemiology Venous Thrombosis - prevention & control COVID-19 low-molecular-weight heparin embolism and thrombosis SARS coronavirus
ISSN:	0014-2972, 1365-2362, 1365-2362
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!